Nathan Rice Analyst PerformanceManaging Director, Healthcare at Piper SandlerNathan Rice is a stock analyst at Piper Sandler in the finance sector, covering 19 publicly traded companies. Over the past year, Nathan Rice has issued 12 stock ratings, including buy and hold recommendations. While full access to Nathan Rice's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Nathan Rice's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings47 Last 8 YearsBuy Recommendations54.35% 25 Buy RatingsCompanies Covered19 Unique Companies Ratings Distribution46RatingsDistribution of strong buy, buy, hold, and sell ratings by Nathan Rice.RatingPercentageCount Strong Buy0.0%0 ratings Buy54.3%25 ratings Hold45.7%21 ratings Sell0.0%0 ratingsOut of 46 total stock ratings issued by Nathan Rice at Piper Sandler, the majority (54.3%) have been Buy recommendations, followed by 45.7% Hold.Best & Worst CallsBest Call000.0%QCRHNov 2018Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%WTFCApr 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ89.5% of companies on NASDAQ17 companiesNYSE10.5% of companies on NYSE2 companiesNathan Rice, an analyst at Piper Sandler, currently covers 19 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageFinance19 companies100.0%Nathan Rice of Piper Sandler specializes in stock coverage within the Finance sector.Coverage IndustriesIndustryPercentageBANKS - MIDWEST13 companies68.4%BANKS - NORTHEAST5 companies26.3%STATE COMMERCIAL BANKS1 company5.3% About Nathan RiceBrandon Rice is a managing director in the Piper Sandler healthcare investment banking group. As a senior member of its medical technology team, he primarily focuses on companies with disruptive technologies. Rice has extensive experience in strategic and capital markets transactions, having executed over 30 M&A deals and more than 80 equity and debt offerings. He is based out of our New York office. Prior to joining Piper Sandler in 2023, Rice spent 17 years at Bank of America Securities, most recently as a managing director in their global healthcare investment banking group. He began his career at Merrill Lynch in 2006, prior to its merger with Bank of America Securities. Rice is a graduate of the Virginia Tech Pamplin College of Business. Nathan Rice's Ratings History at Piper Sandler Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsFMBHFirst Mid Bancshares5/1/2026Reiterated Rating$42.09$55.00Overweight$0.0000.00% ROIBYByline Bancorp4/27/2026Boost Price Target$33.04$40.00Overweight$0.0000.00% ROIBFCBank First National4/20/2026Boost Price Target$140.87$157.00Neutral$0.0000.00% ROIBYByline Bancorp1/27/2026Reiterated Rating$31.20$37.00Overweight$0.0000.00% ROIBFCBank First National1/26/2026Boost Price Target$137.32$150.00Neutral$0.0000.00% ROIFMBHFirst Mid Bancshares11/3/2025Lower Price Target$35.73$48.00Overweight$0.0000.00% ROIMBINMerchants Bancorp10/30/2025Reiterated Rating$31.75$42.00Overweight$0.0000.00% ROIBYByline Bancorp10/28/2025Boost Price Target$27.22$35.00Overweight$0.0000.00% ROIBFCBank First National10/23/2025Boost Price Target$131.13$142.00Neutral$0.0000.00% ROIMBINMerchants Bancorp7/30/2025Reiterated Rating$31.50$41.00Overweight$0.0000.00% ROIFMBHFirst Mid Bancshares7/28/2025Boost Price Target$38.99$49.00Overweight$0.0000.00% ROIBFCBank First National7/21/2025Boost Price Target$127.58$137.00Neutral$0.0000.00% ROIBFCBank First National4/17/2025Boost Price Target$107.36$111.00Neutral$000.0000.00% ROIMBINMerchants Bancorp1/30/2025Boost Price Target$42.35$56.50Overweight$00.0000.00% ROIOSBCOld Second Bancorp10/17/2024Set Price Target$17.16$22.50$00.0000.00% ROIBFCBank First National10/17/2024Boost Price Target$94.07$104.00Neutral$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenJefferies Financial GroupWeiss RatingsUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.The Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
